Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop.

Introduction: The Australasian Teletrial Model was piloted in co-funded sites across Australia. The purpose was to extend the reach of clinical trials using telemedicine to improve equity and access to this treatment pathway for oncology patients. Experts across Australia gathered to share the learnings of implementation so that future directions can be effective and sustainable.

Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institution.

Background: With the rapid influx of novel anti-cancer agents, phase I clinical trials in oncology are evolving. Historically, response rates on early phase trials have been modest with the clinical benefit and ethics of enrolment debated. However, there is a paucity of real-world data in this setting.

'The ones that got away': implementing an exit policy for nurses in a public hospital.

The shortage of registered nurses in Victoria led a Melbourne metropolitan hospital to analyse their recent staff attrition rate. This analysis highlighted the importance of having an exiting policy in place for all departing staff. An exit policy can provide unique opportunities for hospitals to collect information that may help reduce future employee turnover through the identification of the causes of employee dissatisfaction.